Beam Therapeutics Inc.’s BEAM share price has surged by 5.12%, which has investors questioning if this is right time to sell.

Beam Therapeutics (BEAM) saw its shares surge in the last session with trading volume being higher than average. The latest ...

Key Insights Given the large stake in the stock by institutions, Beam Therapeutics' stock price might be vulnerable ...

Verve Therapeutics, Inc.’s VERV share price has surged by 36.18%, which has investors questioning if this is right time to sell.

The equipment for the treatment is tipped to be ₹500 cr and has fewer side effects than traditional radiation therapy ...

EDT Cathie Wood’s ARK Investment buys 135K shares of Beam Therapeutics (BEAM) todayStay Ahead of the Market: Discover outperforming ...

Stifel head of biotech research Paul Matteis suggests looking for biotech names not dependent on the FDA while this sector uncertainty lasts. On March 31, Paul Matteis appeared on CNBC’s ‘The Exchange ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Abu Dhabi is bringing the future of cancer care to the region with a world-class ‘heavy ion therapy’ facility in the UAE. It ...